Free Trial
NASDAQ:ANNX

Annexon (ANNX) Stock Price, News & Analysis

Annexon logo
$2.12 +0.01 (+0.47%)
Closing price 04:00 PM Eastern
Extended Trading
$2.13 +0.01 (+0.71%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Annexon Stock (NASDAQ:ANNX)

Key Stats

Today's Range
$2.09
$2.18
50-Day Range
$2.11
$2.96
52-Week Range
$1.28
$7.85
Volume
843,480 shs
Average Volume
1.20 million shs
Market Capitalization
$232.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.50
Consensus Rating
Moderate Buy

Company Overview

Annexon Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

ANNX MarketRank™: 

Annexon scored higher than 48% of companies evaluated by MarketBeat, and ranked 532nd out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Annexon has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Annexon has only been the subject of 2 research reports in the past 90 days.

  • Read more about Annexon's stock forecast and price target.
  • Earnings Growth

    Earnings for Annexon are expected to decrease in the coming year, from ($0.96) to ($1.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Annexon is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Annexon is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Annexon has a P/B Ratio of 1.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Annexon's valuation and earnings.
  • Percentage of Shares Shorted

    9.94% of the float of Annexon has been sold short.
  • Short Interest Ratio / Days to Cover

    Annexon has a short interest ratio ("days to cover") of 6.5.
  • Change versus previous month

    Short interest in Annexon has recently decreased by 8.04%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Annexon does not currently pay a dividend.

  • Dividend Growth

    Annexon does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.94% of the float of Annexon has been sold short.
  • Short Interest Ratio / Days to Cover

    Annexon has a short interest ratio ("days to cover") of 6.5.
  • Change versus previous month

    Short interest in Annexon has recently decreased by 8.04%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Annexon has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Annexon this week, compared to 3 articles on an average week.
  • Search Interest

    Only 3 people have searched for ANNX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Annexon to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Annexon insiders have bought 25.96% more of their company's stock than they have sold. Specifically, they have bought $20,122.00 in company stock and sold $15,975.00 in company stock.

  • Percentage Held by Insiders

    11.87% of the stock of Annexon is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Annexon's insider trading history.
Receive ANNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Annexon and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ANNX Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Annexon Biosciences (ANNX) Receives a Buy from Wells Fargo
See More Headlines

ANNX Stock Analysis - Frequently Asked Questions

Annexon's stock was trading at $5.13 on January 1st, 2025. Since then, ANNX stock has decreased by 58.7% and is now trading at $2.12.

Annexon, Inc. (NASDAQ:ANNX) posted its earnings results on Thursday, August, 14th. The company reported ($0.34) EPS for the quarter, topping analysts' consensus estimates of ($0.36) by $0.02.

Annexon (ANNX) raised $150 million in an initial public offering on Friday, July 24th 2020. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan, BofA Securities and Cowen acted as the underwriters for the IPO.

Annexon's top institutional investors include Sio Capital Management LLC (3.73%), TFG Asset Management GP Ltd (2.56%), Geode Capital Management LLC (2.08%) and Ameriprise Financial Inc. (1.97%). Insiders that own company stock include Muneer A Satter, Bain Capital Life Sciences Inv, Douglas Love, Michael Overdorf, Jennifer Lew, Ted Yednock, Dean Richard Artis, William H Carson and Jamie Dananberg.
View institutional ownership trends
.

Shares of ANNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Annexon investors own include NVIDIA (NVDA), MercadoLibre (MELI), Advanced Micro Devices (AMD), Meta Platforms (META), CRISPR Therapeutics (CRSP) and Energy Transfer (ET).

Company Calendar

Last Earnings
8/14/2025
Today
8/28/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ANNX
CIK
1528115
Employees
60
Year Founded
N/A

Price Target and Rating

High Price Target
$14.00
Low Price Target
$11.00
Potential Upside/Downside
+489.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$138.20 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-70.04%
Return on Assets
-57.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.67
Quick Ratio
5.67

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.81 per share
Price / Book
1.17

Miscellaneous

Outstanding Shares
109,890,000
Free Float
96,843,000
Market Cap
$232.97 million
Optionable
Optionable
Beta
1.30

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:ANNX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners